Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at CZK 504.7B, ahead of BioNTech (CZK 474.2B) and Biogen (CZK 405.9B). Figures as of 18 Nov 2026, 14:23 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesCZK 504.7B
Median
CZK 44.8B
Combined market value
CZK 18.88T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareCZK 504.7BCZK 4.69TCZK 3,785.05 1.60% up 33% up United States
2BioNTechBNTX · Health CareCZK 474.2BCZK 467.7BCZK 1,886.52 0.47% down 16% down Germany
3BiogenBIIB · Health CareCZK 405.9BCZK 824.1BCZK 5,575.31 0.34% down 49% up United States
4AmgenAMGN · Health CareCZK 192.5BCZK 5.51TCZK 10,180.24 0.95% down 34% up United States
5ModernaMRNA · Health CareCZK 192.3BCZK 1.86TCZK 4,597.37 3.93% down 755% up United States
6argenxARGX · Health CareCZK 162.8BCZK 1.32TCZK 21,064.32 0.36% down 4% up Belgium
7QiagenQGEN · Health CareCZK 84BCZK 228.4BCZK 1,105.99 0.12% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareCZK 72.3BCZK 373.4BCZK 3,688.57 0.37% up 20% up United States
9VaxcytePCVX · Health CareCZK 59.7BCZK 209BCZK 1,320.52 3.59% down 22% up United States
10ExelixisEXEL · Health CareCZK 48BCZK 371.6BCZK 1,522.82 2.09% up 63% up United States
11Bio-TechneTECH · Health CareCZK 46.9BCZK 253.6BCZK 1,614.64 0.22% down 26% up United States
12RepligenRGEN · Health CareCZK 46.8BCZK 230.5BCZK 3,605.42 0.37% down 5% up United States
13CRISPR TherapeuticsCRSP · Health CareCZK 42.7BCZK 86.6BCZK 892.57 0.54% down 21% down Switzerland
14Revolution MedicinesRVMD · Health CareCZK 36.3BCZK 782.3BCZK 3,616.76 2.50% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareCZK 35.1BCZK 230.6BCZK 2,701.51 3.44% down 87% up United States
16Krystal BiotechKRYS · Health CareCZK 27.1BCZK 196.7BCZK 6,637.07 0.22% up 46% up United States
17ImmunovantIMVT · Health CareCZK 19BCZK 152.8BCZK 738.29 0.21% down 43% up United States
18CG OncologyCGON · Health CareCZK 16.7BCZK 156.7BCZK 1,754.92 6.89% down 85% up United States
19Twist BioscienceTWST · Health CareCZK 10.5BCZK 169.8BCZK 2,489.87 6.63% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareCZK 5.5BCZK 122.3BCZK 1,002.17 1.21% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareCZK 4.9BCZK 102.5BCZK 633.36 2.22% up 88% up United States
22Kodiak SciencesKOD · Health CareCZK 3.5BCZK 140.7BCZK 2,151.96 3.90% down 396% up United States
23Halozyme TherapeuticsHALO · Health CareCZK 1.1BCZK 243.2BCZK 2,133.51 0.55% down 37% up United States
24ImmunityBioIBRX · Health Care-CZK 11.1BCZK 148BCZK 139.17 4.68% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2310 CZK).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (CZK 504.7B), BioNTech (CZK 474.2B) and Biogen (CZK 405.9B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 14:23 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of CZK 18.88T as of 18 Nov 2026, 14:23 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.